Gilead Sciences, Inc. (GILD) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.128 -- 00:00:06.029 Good afternoon, everyone, and welcome to Gilead's first quarter 2025 earnings conference 00:00:06.029 -- 00:00:09.751 call. My name is Rebecca, and I'll be today's host. 00:00:09.751 -- 00:00:14.192 In a moment, we'll begin our prepared remarks, followed by our Q&A session. 00:00:14.192 -- 00:00:19.814 To ask a question, please press star one, and to withdraw your question, press star two. 00:00:19.814 -- 00:00:24.495 I'll now hand the call over to Jackie Ross, Senior Vice President of Treasury and Investor 00:00:24.495 -- 00:00:26.495 Relations. 00:00:26.576 -- 00:00:31.429 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:31.429 -- 00:00:36.712 results for the first quarter of 2025. The press release, slides, and supplementary 00:00:36.712 -- 00:00:41.634 data are available on the investor section of our website at gilead.com. 00:00:41.816 -- 00:00:45.658 The speakers on today's call will be our chairman and chief executive officer, Daniel 00:00:45.658 -- 00:00:50.721 O'Day, our chief commercial officer, Joanna Mercier, our chief medical officer, Dietmar 00:00:50.721 -- 00:00:54.564 Berger, and our chief financial officer, Andrew Dickinson. 00:00:54.564 -- 00:00:59.008 After that, we'll open the call to Q&A where the team will be joined by Cindy Peretti, 00:00:59.008 -- 00:01:02.549 the Executive Vice President of KITE. 00:01:02.549 -- 00:01:05.990 Let me remind you that we will be making forward-looking statements. 00:01:05.990 -- 00:01:10.491 Please refer to slide two regarding the risks and uncertainties relating to forward-looking 00:01:10.491 -- 00:01:14.732 statements that could cause actual results to differ materially. 00:01:14.732 -- 00:01:18.472 With that, I'll turn the ca...